Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.410
-0.100 (-3.98%)
At close: Jul 10, 2026, 4:00 PM EDT
2.400
-0.010 (-0.41%)
After-hours: Jul 10, 2026, 6:36 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $54.13 million as of July 10, 2026. Its market cap has increased by 126.02% in one year.
Market Cap
54.13M
Enterprise Value
9.58M
1-Year Change
126.02%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $54.13M, a decrease of -84.79%. That is a compound annual growth rate of -56.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 54.13M | 101.54% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 59.17M |
| eXoZymes | 59.10M |
| Filana Therapeutics | 57.00M |
| Veraxa Biotech AG | 55.48M |
| MiNK Therapeutics | 55.05M |
| Xilio Therapeutics | 54.44M |
| Mereo BioPharma Group | 53.47M |
| aTyr Pharma | 53.38M |